Dr. Oliver Gautschi
Circulating micro-RNA profiling in patients with advanced non-squamous non small-cell lung cancer receiving bevacizumab/erlotinib first-line treatment followed by platinum-based chemotherapy at disease progression (SAKK 19/05)
Apr 1, 2012Background: This study was initiated by the Swiss Group for Clinical Cancer Research (SAKK) 19/05 study to assess the predictive and prognostic value of circulating miRNA profiles from peripheral blood of patients with non-squamous non small-cell lu...
Fundamental Research - Apr 1, 2012 - Sep 1, 2013
Completed
Project leader: Brutsche Martin
Members: Jörger Markus, Zappa Francesco, Gautschi Oliver, Pless Miklos, Ochsenbein Adrian, Bubendorf Lukas, von Moos Roger, Betticher Daniel, Stahel Rolph, Früh Martin, Baty Florent
Der Einfluss von Rauchen auf Rücken- und Kreuzschmerzen: Eine prospektive Kohortenstudie mit einem einjährigen Follow-Up
Oct 1, 2010Viele Studien befassen sich mit der Auswirkung des Rauchens auf Wundheilungsstörungen und, nach orthopädischen Eingriffen, mit der mechanischen Stabilität des Knochens bei Rauchern. Das genaue Schmerzerleben der Patienten, sowie die Auswirkung auf di...
Clinical Studies - Oct 1, 2010 - Oct 31, 2011
Completed
Project leader: Hildebrandt Gerhard
Members: Stienen Martin N., Gautschi Oliver
Short or intermediate time to return to work after mild traumatic brain injury: A randomized parallel group study with a one-year follow-up
Dec 1, 2009Das Ziel der Studie ist, aus den gewonnenen Daten Behandlungsalgorhythmen zu entwickeln, welche die Inzidenz des postcommotionellen Syndroms senken, sozio-ökonomische Kosten reduzieren, den Patienten eine raschere Wiedereingliederung in den Berufsall...
Clinical Studies - Dec 1, 2009 - Aug 1, 2012
Automatically Closed
Project leader: Gautschi Oliver
A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping
Sep 1, 2007Aneurysmal subarachnoid hemorrhage has been designated as an orphan disease and remains an important cause of morbidity and mortality despite advances in medical and surgical therapy. One important complication of subarachnoid hemorrhage is cerebral...
Clinical Studies - Sep 1, 2007 - Mar 31, 2010
Automatically Closed
Project leader: Seule Martin, Hildebrandt Gerhard
Members: Gautschi Oliver